A Strategic Evaluation of the Maryland Research and Development Tax Credit: Addressing the Impasse of Statutory Global Caps and Proration Mechanisms for Small and Medium Enterprises

Author: Clariza Arquinez | Maryland R&D Tax Policy Consultant
Published: July 31, 2026 | Series: Swanson Reed State Tax Incentives

Answer Capsule: Why Is Maryland’s R&D Tax Credit Proration Harmful to SMBs?

Maryland’s R&D Tax Credit operates under a static $12 million annual global cap, divided into an $8.5 million pool for large corporations and a critically underfunded $3.5 million set-aside for small businesses. Because statewide research expenditures perennially dwarf this cap, the Department of Commerce is forced to mathematically prorate all certified claims. This turns a statutory 10% growth credit into an unpredictable fraction (often falling below 1.2%), destroying the financial predictability required by early-stage innovators. To compete with neighboring states like Pennsylvania, Maryland must aggressively phase its global cap to $50 million and introduce a Transferability Program, allowing pre-revenue startups to monetize their credits immediately on the private market.

Key Takeaways

The Proration Penalty: Unpredictable proration transforms the R&D credit into a “shared-pool lottery,” where the effective value of the credit plummets as aggregate state innovation increases, systematically penalizing success and discouraging strategic capital forecasting.
The Competitive Deficit: Neighboring Pennsylvania boasts a $60 million cap with a dedicated $12 million small business set-aside and a 20% small business rate. Maryland’s $3.5 million set-aside is critically inadequate to anchor the region’s top-tier biotechnology and cybersecurity talent.
Proposed Solution 1 (Phased Cap Expansion): Legislatively authorize a three-year phased expansion of the global cap from $12 million to $50 million, securing a minimum $15 million specifically insulated for Small and Medium Businesses to end destructive dilution.
Proposed Solution 2 (Credit Transferability): Establish a “Technology Business Tax Certificate Transfer Program” allowing pre-revenue startups to sell their certified credits to profitable Maryland corporations at 90-95 cents on the dollar, delivering immediate, non-dilutive liquidity.
Fraud Prevention Framework: Mandate a “Dual-Professional Sign-Off” (Technical Engineer and CPA) for high-value claims, integrated dynamically with the Comptroller’s new “SMART” cloud-based tax system to cross-reference UI records and eliminate “ghost employee” fraud.

1. Executive Summary

The economic vitality of the State of Maryland is inextricably linked to its status as a premier global hub for innovation, particularly within the “lighthouse industries” of biotechnology, life sciences, cybersecurity, and advanced manufacturing.¹ Central to this competitive positioning is the Maryland Research and Development (R&D) Tax Credit, a fiscal incentive established under Maryland Tax-General Article § 10-721 intended to catalyze private sector investment in high-technology experimentation.¹ However, the program’s utility as a primary driver of economic development is currently constrained by a structural paradox: a static $12 million annual global cap and a mandatory proration mechanism that penalizes success by diluting the value of the credit as aggregate research expenditures increase.¹

For the small and medium-sized business (SMB) community, which represents the most sensitive and high-growth segment of the innovation ecosystem, this proration creates an environment of fiscal uncertainty that undermines the very predictability required for long-term capital planning.⁵ This whitepaper provides an exhaustive analysis of the current statutory framework, the deleterious effects of the proration mechanism on SMBs, and offers a comprehensive roadmap for legislative reform designed to secure Maryland’s leadership in the 21st-century innovation economy.

2. The Statutory Architecture and Historical Evolution of Maryland’s R&D Incentive

The Maryland R&D Tax Credit was designed as a sophisticated instrument to lower the after-tax cost of domestic research, thereby incentivizing firms to anchor their high-value activities within the state.¹ To understand the current policy crisis, one must first examine the rigorous qualifying criteria and the evolution of the calculation methodology. Maryland strictly adheres to the federal definition of “qualified research” as defined in Section 41(d) of the Internal Revenue Code (IRC), commonly known as the “Four-Part Test”.¹

The Four-Part Test of Eligibility

For an activity to qualify for the Maryland credit, it must satisfy four distinct legal and technical hurdles. First, the research must be “technological in nature,” relying on the hard sciences such as biology, physics, or computer science; social sciences and market research are explicitly excluded.¹ Second, the activity must have a “permitted purpose,” specifically to create a new or improved business component, such as a product, process, or software.¹ Third, the taxpayer must demonstrate the “elimination of technical uncertainty,” meaning the information available at the outset does not establish the capability or method for the desired result.¹ Finally, the research must involve a “process of experimentation,” which requires a systematic evaluation of alternatives through trial and error or the scientific method.¹

Table 1: The Four-Part Test Framework

Eligibility Criterion	Statutory Requirement	Focus Areas
Technological Nature	Hard sciences requirement	Biological, physical, engineering, computer science
Permitted Purpose	Component improvement	Functionality, performance, reliability, quality
Elimination of Uncertainty	Capability or design	Methodical resolution of technical roadblocks
Process of Experimentation	Systematic evaluation	Modeling, simulation, trial and error, testing

Transition from Basic to Growth Methodology

Prior to 2021, the Maryland framework offered two distinct credits: a “Basic” credit of 3% for expenses up to a historical base amount, and a “Growth” credit of 10% for expenses exceeding that base.³ In a significant reform effort via Chapter 114 of 2021, the General Assembly eliminated the Basic credit to streamline the program and focus state resources exclusively on incremental growth.³ This shift reflected a policy preference for rewarding businesses that actively increase their R&D footprint in Maryland, rather than those merely maintaining a baseline of activity.³ Under the current regime, the 10% growth credit is calculated against Maryland Qualified Research Expenses (QREs) that exceed a “Maryland Base Amount,” which is derived from the firm’s historical ratio of R&D spending to gross receipts over the preceding four taxable years.¹

3. The Impasse of the Global Cap and the Proration Mechanism

While the 10% statutory rate is competitive on paper, the presence of a $12 million aggregate cap creates a “glass ceiling” for the program’s effectiveness.¹ This cap is divided into two separate pools: $8.5 million for large corporations and a $3.5 million set-aside for small businesses.¹ When the total amount of certified credits applied for by all businesses exceeds these limits—as has occurred in every recent fiscal year—the Department of Commerce is legally obligated to reduce every applicant’s credit proportionally.¹

The Mathematical Reality of Oversubscription

The proration mechanism transforms a “statutory entitlement” into a “shared-pool lottery”.⁵ As more businesses innovate and as existing firms expand their research budgets, the “effective” credit rate drops.⁴ Historical data illustrates a stark divergence between the 10% rate intended by the legislature and the actual benefit received by taxpayers.⁵

Table 2: Historical Proration Impact

Tax Year	Total Requested Credits (Estimated)	Effective Growth Rate Post-Proration	Effective Basic Rate (Pre-2021)
2009	$37.4 Million	2.76%	0.34%
2015	$82.1 Million	0.95%	0.39%
2023	>$100 Million	<1.20%	N/A (Repealed)

In the 2015 cycle, the growth credit was prorated so severely that participants received less than 10% of their qualified claim.⁵ For an SMB that budgeted for a $100,000 credit to fund a new laboratory technician, receiving a mere $9,500 represents a catastrophic failure of the policy to provide reliable capital.⁵

The Disproportionate Burden on Small and Medium Businesses

SMBs are uniquely vulnerable to the proration mechanism due to their reliance on the credit for immediate liquidity.¹⁵ Unlike large, multi-state corporations that can absorb a reduction in a state-level credit or carry forward unused portions for up to seven years to offset future profits, many Maryland startups are pre-revenue or in early-stage growth.⁹ For these firms, the R&D credit is refundable.⁴ This refundability is a critical lifeline, often representing the only non-dilutive funding available to a biotech startup trying to reach its next clinical milestone or a cybersecurity firm developing a novel encryption protocol.¹⁶

The current $3.5 million small business set-aside is fundamentally inadequate to meet the needs of Maryland’s burgeoning tech sector.¹ In 2015, if the set-aside had been in place at current levels, small businesses would have received an average of $22,300, but under the oversubscribed reality of the time, they received only $2,800.⁵ This gap between expectation and reality creates a “trust deficit” where SMBs stop factoring the credit into their strategic growth decisions, viewing it instead as a minor and unpredictable bonus rather than a significant incentive to expand.¹⁹

4. Comparative Analysis: Maryland’s Competitive Disadvantage in the Region

To remain a leader in the mid-Atlantic innovation corridor, Maryland must compete with the aggressive incentive structures of neighboring states, most notably Pennsylvania.²⁰ Pennsylvania’s approach to the R&D credit offers a cautionary tale of how a more robust cap can drive superior economic outcomes.

The Pennsylvania Benchmark

Pennsylvania’s R&D tax credit program is currently capped at $60 million annually—five times the size of Maryland’s pool.²¹ Within this cap, $12 million is reserved exclusively for small businesses, a set-aside that is nearly 3.5 times larger than Maryland’s.²¹ Furthermore, Pennsylvania provides a higher statutory credit rate of 20% for small businesses, compared to 10% for large firms, specifically acknowledging that smaller firms face greater financial constraints and require a more potent incentive.²¹

Table 3: Regional Policy Comparison

Feature	Maryland	Pennsylvania	Virginia
Global Cap	$12 Million	$60 Million	~$7.77 Million (Small Credit)
SMB Set-Aside	$3.5 Million	$12 Million	Full (dedicated program)
Small Biz Rate	10%	20%	15% – 20%
Refundability	Yes (SMB Only)	No	Yes (SMB Only)
Transferability	No	Yes	No
Carryforward	7 Years	15 Years	0 to 10 Years

Pennsylvania also allows for the transferability (sale) of credits.²³ This enables pre-revenue small businesses to sell their credits to profitable firms, often retaining 92 to 94 cents per dollar of value.²³ In contrast, Maryland’s SMBs are locked into a refundable system that is subject to the whims of the annual proration factor, making the “realized” value far less certain than the “marketable” value seen in Pennsylvania.¹

The Virginia Warning

Virginia’s experience provides a different warning.²⁶ Following a JLARC evaluation which found that the state’s R&D credits were too small to meaningfully move the needle on statewide innovation, the credits were allowed to sunset in early 2025.²⁶ This created an immediate competitive vacuum, which Maryland should ideally fill.²⁶ However, if Maryland maintains its current $12 million cap, it remains “stuck in the middle”—too small to be a primary driver of major corporate location decisions, and too unpredictable to serve as a reliable foundation for small business growth.¹⁹

5. Practical Solution 1: Phased Cap Expansion and Indexing to Research Volume

The most direct and effective solution to the proration crisis is a significant, phased increase of the aggregate cap to align with the actual volume of research being conducted in Maryland.

Implementation of a $50 Million Growth Cap

The Maryland legislature should authorize a phased increase of the global cap from $12 million to $50 million over a three-year period. This expansion would provide the fiscal “breathing room” necessary to eliminate proration in most years, thereby restoring the statutory 10% rate as a reliable figure for business planning.²¹

Year 1: Increase cap to $25 million ($7.5 million small business set-aside).
Year 2: Increase cap to $35 million ($10 million small business set-aside).
Year 3: Increase cap to $50 million ($15 million small business set-aside).

By increasing the small business set-aside to $15 million, Maryland would surpass Pennsylvania’s $12 million benchmark, signaling to the national venture capital and biotech communities that Maryland is the most supportive environment for early-stage innovation.²¹

Dynamic Cap Indexing

To prevent the recurrence of the proration issue as the economy grows, the legislature should consider indexing the cap to the total volume of certified QREs in the state. For example, the cap could be set at 2% of the total Maryland QREs reported in the preceding two years.¹⁰ This would ensure that the incentive grows in lockstep with the success of the state’s innovation policy, rather than remaining an arbitrary static number that effectively penalizes the state’s economic progress.²⁸

6. Practical Solution 2: The Technology Business Tax Certificate Transfer Program

To address the liquidity needs of SMBs without placing an immediate strain on the general fund via refunds, Maryland should establish a “Technology Business Tax Certificate Transfer Program.” This model, utilized effectively in New Jersey and proposed in various forms during the 2025-2026 Maryland sessions (e.g., HB 35), allows small businesses to “sell” their certified R&D credits to profitable Maryland corporations.²⁹

Operational Mechanism

Under this program, a small business with assets under $5 million that receives a certification from the Department of Commerce would have the option to either claim a refund (subject to the $3.5 million cap) or “transfer” the credit to a third party.²⁹ Profitable firms—such as major utilities, retail chains, or financial institutions—would purchase these credits at a slight discount (e.g., 90-95 cents on the dollar) to use against their own corporate income tax liability.²³

Benefits for the State and the SMB

This solution creates a private-market infusion of capital for startups.²⁹ It reduces the immediate cash-outlay requirement for the state, as the revenue loss only occurs when the purchaser files its return, which may be in a different fiscal quarter or year.²⁹ Furthermore, it creates a “virtuous cycle” of investment where established Maryland industries are directly supporting the state’s emerging tech leaders. To ensure this benefit reaches those most in need, the program could be restricted to firms with fewer than 225 employees and an asset base under $5 million.²⁹

7. Implementation Strategy: Ensuring Program Integrity and Preventing Wastage

Expanding a tax credit program requires a concomitant investment in oversight to ensure that the expansion does not lead to “tax leakage” through fraudulent or wasteful claims.⁷

Leveraging the “SMART” Cloud-Based Tax System

The Maryland Comptroller’s Office is currently transitioning to a new, cloud-based tax processing system (“SMART”), expected to be fully operational by 2026.³² This system should be integrated with the Department of Commerce’s application portal to enable automated data-matching. By cross-referencing R&D wage claims against state unemployment insurance (UI) records, the government can instantly verify the existence of the employees and the accuracy of the wages reported.³¹ This proactive verification prevents the “ghost employee” fraud common in unmonitored incentive programs.³¹

Mandatory Multi-Disciplinary Pre-Certification

To fix the issue of inflated claims, the state should mandate a “Dual-Professional Sign-Off” for applications exceeding a certain dollar threshold.⁷ Under this framework, a business must submit:

A Technical Certification: Signed by a qualified engineer or scientist in the relevant field, attesting that the projects meet the IRC § 41(d) “process of experimentation” requirement.⁷
A Financial Certification: Signed by a CPA, attesting that the costs (wages, supplies, and 65% of contract research) are accurately extracted from the firm’s financial records.⁷

This requirement shifts the burden of initial due diligence to licensed professionals who are governed by ethical standards (e.g., Circular 230), thereby reducing the state’s audit overhead and ensuring that only high-quality, legitimate research is subsidized.⁷

Audit and Recovery Provisions

The Department of Commerce should be granted enhanced authority to perform spot audits and recover funds from firms that misrepresent their activities.¹³ By implementing a “Risk-Based Monitoring” framework—where applications showing anomalous spending spikes or inconsistent documentation are flagged for manual review—the state can maintain the integrity of the program even as the volume of credits increases.³¹

8. Fiscal Impact and Investment Analysis: The Future Payoff

A common critique of expanding the R&D tax credit is the immediate “cost” to the general fund.³⁵ However, a professional economic analysis must view this as a capital investment in the state’s future tax base.

The Leverage Effect

Maryland’s R&D credit currently achieves a leverage ratio of approximately 175:1.¹⁰ For every $1 million in credits awarded, companies are committing roughly $175 million in private research expenditures within the state.¹⁰ This spending translates directly into:

High-Wage Payroll: Supporting thousands of STEM professionals with an average salary of $105,000.¹⁰
Ancillary Economic Activity: Every 1.0 direct R&D job in Maryland supports an additional 1.4 to 1.7 induced and indirect jobs in the surrounding community (e.g., logistics, services, housing).³⁷

Table 4: Fiscal Investment Multipliers

Investment Factor	Impact Metric	Future Revenue Source
Initial State Cost	$50 Million (Proposed Cap)	General Fund Revenue
Private R&D Leverage	~$8.7 Billion in Activity	Indirect & Induced Taxes
Direct Job Creation	~2,000 to 5,000 New STEM Roles	Personal Income Tax
Facility Expansion	Increased Real Property Value	Local Property Tax

The “Payback” Period

While the $38 million increase in the cap (from $12M to $50M) represents an immediate revenue reduction, the “dynamic” revenue effects often offset this within a 5-to-10-year window.³⁷ As startups commercialize their research, they transition from pre-revenue (receiving refunds) to highly profitable (paying corporate income tax).³⁷ Furthermore, the retention of a single major biotech or cybersecurity firm that might otherwise have relocated to Pennsylvania can save the state millions in lost future tax revenue and “brain drain” costs.²⁰

9. The Importance of Policy Change vs. The Cost of Inaction

Maryland stands at a critical juncture. The Governor’s “DECADE Act” of 2026 correctly identifies that the state’s economic competitiveness depends on making “big bets” on its lighthouse industries.² However, extending a broken system—one where the cap is too low and proration is the norm—is not a “big bet”; it is a maintenance of the status quo.²

Negative Consequences of Inaction

If the $12 million cap remains, Maryland will face several structural threats:

Capital Flight: Venture capital-backed startups are increasingly mobile.⁸ If a founder realizes that Maryland’s R&D credit is essentially a “token” benefit due to proration, they are more likely to site their next laboratory in a state with a predictable 20% credit like Pennsylvania.²¹
Stagnation in the Small Business Sector: The “middle market” of firms—those that have outgrown “startup” status but are not yet large corporations—is currently underserved by the $3.5 million set-aside.⁵ Without a cap increase, these firms will continue to see their incentives dwindle just as they are attempting to scale their manufacturing and research operations.⁵
Inefficiency and “Check-the-Box” R&D: When the credit value is uncertain and small, firms treat it as an administrative exercise rather than a strategic incentive.¹⁹ This results in “waste” where the government provides a benefit that doesn’t actually influence business decisions—the very outcome the DLS evaluation feared.¹⁹

The Vision for a Reinvigorated Maryland

Fixing the proration issue is about more than just numbers; it is about providing the “certainty” that innovation requires.² A $50 million cap, combined with transferability for small firms, would position Maryland as the undisputed leader in innovation policy on the East Coast.² It would signal to every scientist, engineer, and entrepreneur that the State of Maryland is not just a participant in the research economy, but its most dedicated partner. By aligning fiscal policy with technical reality, the Maryland Legislature can ensure that the next generation of life-saving therapies and nation-securing technologies are “Made in Maryland.”

10. Works Cited

Research and Development (R&D) Tax Credits for Laurel, Maryland Businesses – Swanson Reed, accessed March 21, 2026, https://www.swansonreed.com/research-tax-credit/maryland/case-studies/laurel/
Governor Moore Announces Legislative Action to Strengthen Maryland’s Economic Competitiveness – Press Releases – News, accessed March 21, 2026, https://governor.maryland.gov/news/press/pages/governor-moore-announces-legislative-action-to-strengthen-maryland%E2%80%99s-economic-competitiveness.aspx
Department of Business and Economic Development (Prior Name of DOC) – Swanson Reed, accessed March 21, 2026, https://www.swansonreed.com/research-tax-credit/maryland/glossary/department-of-business-and-economic-development/
Research and Development Tax Credit (R&D) – Maryland Commerce, accessed March 21, 2026, https://commerce.maryland.gov/fund/programs-for-businesses/research-and-development-tax-credit
2018 Regular Session – Fiscal and Policy Note for House Bill 1450, accessed March 21, 2026, https://mgaleg.maryland.gov/2018RS/fnotes/bil_0000/hb1450.pdf
Are R&D Tax Credits Available in Maryland? | See if You Qualify – KBKG, accessed March 21, 2026, https://www.kbkg.com/research-tax-credit/maryland-rd-tax-credit
Common R&D tax credit scams to avoid, accessed March 21, 2026, https://www.swansonreed.com/research-tax-credit/federal/faqs/common-rd-tax-credit-scams-to-avoid/
Pennsylvania R&D Tax Credit Consultants – Arvo Tech, accessed March 21, 2026, https://arvotech.com/resources/blog/pennsylvania-rd-tax-credit-consultants
Maryland R&D Tax Credit Overview for Businesses – Swanson Reed, accessed March 21, 2026, https://www.swansonreed.com/research-tax-credit/maryland/
Maryland Department of Commerce Fiscal 2021 Annual Report, accessed March 21, 2026, https://dlslibrary.state.md.us/publications/Exec/DC/commerce-annual-report-2021.pdf
Consolidated Incentives Performance Report – Maryland Commerce, accessed March 21, 2026, https://commerce.maryland.gov/Documents/ProgramReport/maryland-jobs-development-act-executive-report-FY21.pdf
Controlled Group of Corporations (Single Taxpayer Rule) – Swanson Reed, accessed March 21, 2026, https://www.swansonreed.com/research-tax-credit/maryland/glossary/controlled-group-of-corporations-single-taxpayer-rule/
Maryland Tax – General Code Section 10-721 (2024) – Qualified Research and Development Expenses. [Effective Until June 30, 2027] – Justia Law, accessed March 21, 2026, https://law.justia.com/codes/maryland/tax-general/title-10/subtitle-7/section-10-721/
maryland research and development tax credit program annual status report tax year 2009 tax-general, accessed March 21, 2026, https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/020000/020706/unrestricted/20150045e.pdf
Maryland Research and Development Tax Credit – Endeavor Advisors, accessed March 21, 2026, https://www.endeavoradvisors.com/maryland-rd-tax-credit/
State R&D Tax Credits for Biotech: The Hidden Opportunity Most Life Sciences Companies Miss – Boast, accessed March 21, 2026, https://www.boast.ai/en-us/blog/r-and-d/state-rd-tax-credits-for-biotech-the-hidden-opportunity-most-life-sciences-companies-miss
Maryland R&D Tax Credits – Get Info and Calculate R&D Tax Credits – Strike Tax Advisory, accessed March 21, 2026, https://www.striketax.com/state-rd-credits/maryland-r-d-tax-credits
Biotechnology Investment Incentive Tax Credit (BIITC) – Maryland Commerce, accessed March 21, 2026, https://commerce.maryland.gov/fund/programs-for-businesses/bio-tax-credit
Appendix F: R&D tax incentives by state – JLARC, accessed March 21, 2026, https://jlarc.virginia.gov/pdfs/oversight/ED_initiatives/SciTech%20Appendix%20F.pdf
Understanding tax differences between Maryland and Virginia | Beltway Movers DMV, accessed March 21, 2026, https://www.beltwaymovers.com/understanding-tax-differences-between-maryland-and-virginia/
2025 Research & Development Tax Credit Report to the Pennsylvania General Assembly (DOP-26), accessed March 21, 2026, https://www.pa.gov/content/dam/copapwp-pagov/en/revenue/documents/news-and-statistics/reportsstats/taxcredits/researchdevcredit/documents/2025_rd_report.pdf
Are R&D Tax Credits Available in Pennsylvania? | See if You Qualify – KBKG, accessed March 21, 2026, https://www.kbkg.com/research-tax-credit/pennsylvania-rd-tax-credit
Pennsylvania R&D Tax Credit Services – James Moore, accessed March 21, 2026, https://www.jmco.com/tax/r-and-d-tax-credit-services/pennsylvania/
R&D Tax Credit Program | Department of Revenue – Commonwealth of Pennsylvania, accessed March 21, 2026, https://www.pa.gov/agencies/revenue/incentives-credits-and-programs/tax-credits/r&d-tax-credit-program
States Spend Big on R&D Tax Credits. Are They Paying Off? – Governing, accessed March 21, 2026, https://www.governing.com/finance/states-spend-big-on-r-d-tax-credits-are-they-paying-off
Virginia R&D Tax Credit: 2025 Sunset Implications and 2026 Outlook | Cherry Bekaert, accessed March 21, 2026, https://www.cbh.com/insights/articles/virginia-rd-tax-credit-changes-impact-on-businesses/
RD142 (Published 2023) – Science and Technology Incentives: Economic Development Incentives Evaluation Series – June 13, 2022, accessed March 21, 2026, https://rga.lis.virginia.gov/Published/2023/RD142
Evaluation of the Research and Development Tax Credit – Maryland Department of Legislative Services, accessed March 21, 2026, https://dls.maryland.gov/pubs/prod/TaxFiscalPlan/Evaluation-of-the-Research-and-Development-Tax-Credit-2024.pdf
2025 Regular Session – Fiscal and Policy Note for House Bill 35 – Maryland, accessed March 21, 2026, https://mgaleg.maryland.gov/2025RS/fnotes/bil_0005/hb0035.pdf
2026 Regular Session – Fiscal and Policy Note for Senate Bill 388 – Maryland, accessed March 21, 2026, https://www.mgaleg.maryland.gov/2026RS/fnotes/bil_0008/sb0388.pdf
Combating Fraud, Waste and Abuse in Government Entitlement Programs | RELI Group Inc., accessed March 21, 2026, https://www.religroupinc.com/news-insights/combating-fraud-waste-and-abuse-in-government-entitlement-programs/
State of Maryland 2024 Annual Comprehensive Financial Report, accessed March 21, 2026, https://www.marylandcomptroller.gov/content/dam/mdcomp/md/reports/financial/acfr2024.pdf
Federal Awards: Selected Programs Did Not Fully Include Identified Practices to Enhance Oversight and Fraud Prevention – GAO, accessed March 21, 2026, https://www.gao.gov/products/gao-26-107444
GAO Says Federal Award Programs Lack Complete Fraud-Prevention Safeguards, accessed March 21, 2026, https://www.executivegov.com/articles/gao-federal-award-programs-fraud-prevention
Corporate Tax Cut Would Harm Maryland’s Economic Growth, accessed March 21, 2026, https://mdeconomy.org/corporate-tax-cut-would-harm-marylands-economic-growth-2/
Maryland Releases 60-Day Report on Revenue Effects of OBBBA – BDO USA, accessed March 21, 2026, https://www.bdo.com/insights/tax/maryland-releases-60-day-report-on-revenue-effects-of-obbba
The Economic and Fiscal Impacts of TEDCO’s Five Core Programs, accessed March 21, 2026, https://www.tedcomd.com/sites/default/files/2019-02/TEDCO%202018%20Final.pdf
Maryland Department of Commerce Programs Supported 24,000 …, accessed March 21, 2026, https://governor.maryland.gov/news/press/pages/Maryland-Department-of-Commerce-Programs-Supported-24,000-Jobs-in-FY-2025.aspx
MEDA Study Shows Record Return on Investment for County Economic Development in Maryland, accessed March 21, 2026, https://www.medamd.com/public-policy-awareness/meda-study-shows-record-return-on-investment-for-county-economic-development-in-maryland/
The 2025 Guide to State R&D Tax Credits | TaxTaker, accessed March 21, 2026, https://www.taxtaker.com/blog/the-2025-guide-to-state-r-d-tax-credits
New Opportunities for Job Creation in Maryland’s Life Sciences Industry, accessed March 21, 2026, https://mdtechcouncil.com/wp-content/uploads/2021/10/JobCreation-MarylandLifeSciences_Milken.pdf
Governor Moore Kicks Off 2026 Legislative Session with Ambitious Agenda to Invest in Education, Enhance Public Safety, and Create More Affordable Housing for Marylanders – Press Releases – News, accessed March 21, 2026, https://governor.maryland.gov/news/press/pages/Governor-Moore-Kicks-Off-2026-Legislative-Session-with-Ambitious-Agenda-to-Invest-in-Education,-Enhance-Public-Safety,-and-.aspx
Pennsylvania R&D Tax Credits 101: Your Complete Guide to State-Level Innovation Funding – Boast.AI, accessed March 21, 2026, https://www.boast.ai/en-ca/blog/rd/pennsylvania-rd-tax-credits-101-your-complete-guide-to-state-level-innovation-funding

Notice & Disclaimer: The information is current as of July 31, 2026. This whitepaper is provided for discussion purposes only and should not be construed as legal or tax advice. It is strongly recommended that you seek professional legal or tax representation to understand how the Maryland R&D tax credit and any proposed policy changes would apply to specific business circumstances.